Early result of heart transplantation in Japan: Osaka University experience

Asian Cardiovascular and Thoracic Annals

Volumn 12, Issue 2, 2004, Pages 154-158

  Fukushima, Norihide ^a,b   Miyamoto, Yuji ^a   Ohtake, Shigeaki ^a   Sawa, Yoshiki ^a   Takahashi, Toshiki ^a   Nishimura, Motonobu ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NONE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; DOBUTAMINE; DOPAMINE; GANCICLOVIR; IMMUNOGLOBULIN; INOTROPIC AGENT; MAGNESIUM SULFATE; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; POTASSIUM; PREDNISOLONE; STEROID; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; ASSISTED CIRCULATION; CARDIOMYOPATHY; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DAILY LIFE ACTIVITY; DEATH; DRUG BLOOD LEVEL; FEMALE; FOLLOW UP; GRAFT REJECTION; HEART TRANSPLANTATION; HEART VENTRICLE TACHYCARDIA; HEMODYNAMICS; HOSPITAL DISCHARGE; HUMAN; HUMAN TISSUE; HUMORAL IMMUNITY; HYPERTROPHIC CARDIOMYOPATHY; IMMUNOSUPPRESSIVE TREATMENT; JAPAN; KIDNEY DYSFUNCTION; MALE; MYOCARDITIS; NEUROLOGIC DISEASE; ORGAN DONOR; PLASMAPHERESIS; RESUSCITATION; SCHOOL CHILD; SURGICAL MORTALITY; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

EID: 3543020388     PISSN: 02184923     EISSN: None     Source Type: Journal    
DOI: 10.1177/021849230401200215     Document Type: Article

References (16)

1. Hosenpud JD, Bennett LE, Keck BM, Fiol B, Boueek MM, Novick RJ. The Registry of the International Society for Heart and Lung Transplantation: 15th official report-1998. J Heart Lung Transplant 1998;17:656-68.
2. Matsuda H, Fukushima N, Sawa Y, Nishimura M, Matsumiya G, Shirakura R. First brain dead donor heart transplantation under new legislation in Japan. Jpn J Thorac Cardiovasc Surg 1999;47:499-505.
3. Aono T, Kondo K, Miyoshi H, Tanaka-Taya K, Kondo M, Osugi Y, et al. Monitoring of human cytomegalovirus infections in pediatric bone marrow transplant recipients by nucleic acid sequence-based amplification. J Infect Dis 1998;178;1244-9.
4. Fukushima N, Shirakura R, Nakata S, Kaneko M, Sawa Y, Matsuwaka R, et al. Effects of terminal cardioplegia with leukocyte-depleted blood on heart grafts preserved for 24 hours. J Heart Lung Transplant 1992;11:676-82.
5. Shumway NE, Lower RR, Stofer RC. Transplantation of the heart. Adv Surg 1966;2:265-84.
6. Bailey L, Concepcion W, Shattuck H, Huang L. Method of heart transplantation for treatment of hypoplastic left heart syndrome. J Thorac Cardiovasc Surg 1986;92:1-5.
7. Kitamura S, Nakatani T, Bando K, Sasako Y, Kobayashi J, Yagihara T. Modification of bicaval anastomosis technique for orthotopic heart transplantation. Ann Thorac Surg 2001;72:1405-6.
8. Billingham ME, Cary NR, Hammond ME, Kemnitz J, Marboe C, McCallister HA, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant 1990;9:587-93.
9. Fullerton DA, Gundry SR, Alonso de Begona J, Kawauchi M, Razzouk AJ, Bailey LL. The effects of donor-recipient size disparity in infant and pediatric heart transplantation. J Thorac Cardiovasc Surg 1992;104:1314-9.
10. Fukushima N, Gundry SR, Razzouk AJ, Bailey LL. Growth of oversized grafts in neonatal heart transplantation. Ann Thorac Surg 1995;60:1659-63.
11. Kobashigawa JA, Katznelson S, Laks H, Johnson JA, Yeatman L, Wang XM, et al. Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med 1995;333:621-7.
12. Sawa Y, Matsuda H. Myocardial protection with leukocyte depletion in cardiac surgery. Semin Thorac Cardiovasc Surg 2001;13:73-81.
13. Kobashigawa J, Miller L, Renlund D, Mentzer R, Alderman E, Bourge R, et al. Randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators. Transplantation 1998;66:507-15.
14. Banner NR, David OJ, Leaver N, Davis J, Breen J, Johnston A, et al. Pharmacokinetics of oral cyclosporine (Neoral) in heart transplant recipients during the immediate period after surgery. Transpl Int 2002;15:649-54.
15. DeNofrio D, Rho R, Morales FJ, Kamoun M, Kearns J, Dorozinsky C, et al. Detection of anti-HLA antibody by flow cytometry in patients with a left ventricular assist device is associated with early rejection following heart transplantation. Transplantation 2000;69:814-8.
16. Nakatani T, Sasako Y, Kobayashi J, Yamamoto F, Kumon K, Kosakai Y, et al. Application of ventricular assist systems for end-stage cardiomyopathy patients as a bridge to heart transplant or recovery. Transplant Proc 1999;31:2000-1.